Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:42 UTC |
---|
HMDB ID | HMDB0014665 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Metolazone |
---|
Description | Metolazone is only found in individuals that have used or taken this drug. It is a quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic renal failure. It also tends to lower blood pressure and increase potassium loss. [PubChem]The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption. Metolazone acts primarily to inhibit sodium reabsorption at the cortical diluting site and to a lesser extent in the proximal convoluted tubule. Sodium and chloride ions are excreted in approximately equivalent amounts. The increased delivery of sodium to the distal tubular exchange site results in increased potassium excretion. Metolazone does not inhibit carbonic anhydrase. The antihypertensive mechanism of action of metolazone is not fully understood but is presumed to be related to its saluretic and diuretic properties. |
---|
Structure | CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23) |
---|
Synonyms | Value | Source |
---|
2-Methyl-3-O-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone | ChEBI | 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide | ChEBI | 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-O-tolyl-6-quinazolinesulfonamide | ChEBI | Metolazona | ChEBI | Metolazonum | ChEBI | Zaroxolyn | ChEBI | 2-Methyl-3-O-tolyl-6-sulphamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone | Generator | 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulphonamide | Generator | 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-O-tolyl-6-quinazolinesulphonamide | Generator | Microx | HMDB | Mykrox | HMDB | Celltech pharmaceuticals brand OF metolzone | HMDB | Diulo | HMDB | UCB pharma brand OF metolazone | HMDB |
|
---|
Chemical Formula | C16H16ClN3O3S |
---|
Average Molecular Weight | 365.835 |
---|
Monoisotopic Molecular Weight | 365.06008979 |
---|
IUPAC Name | 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide |
---|
Traditional Name | metolazone |
---|
CAS Registry Number | 17560-51-9 |
---|
SMILES | CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O |
---|
InChI Identifier | InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23) |
---|
InChI Key | AQCHWTWZEMGIFD-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinazolines. Quinazolines are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Quinazolines |
---|
Alternative Parents | |
---|
Substituents | - Quinazoline
- Secondary aliphatic/aromatic amine
- Toluene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Organosulfonic acid amide
- Organic sulfonic acid or derivatives
- Vinylogous amide
- Aminosulfonyl compound
- Tertiary carboxylic acid amide
- Sulfonyl
- Organosulfonic acid or derivatives
- Amino acid or derivatives
- Carboxamide group
- Lactam
- Carboxylic acid derivative
- Secondary amine
- Azacycle
- Organic oxide
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Amine
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 256 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.041 g/L | Not Available | LogP | 2.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Metolazone,1TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C)=C(Cl)C=C2NC1C | 3130.8 | Semi standard non polar | 33892256 | Metolazone,1TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C)=C(Cl)C=C2NC1C | 3198.8 | Standard non polar | 33892256 | Metolazone,1TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C)=C(Cl)C=C2NC1C | 4229.7 | Standard polar | 33892256 | Metolazone,1TMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(N)(=O)=O)=C(Cl)C=C2N([Si](C)(C)C)C1C | 2979.5 | Semi standard non polar | 33892256 | Metolazone,1TMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(N)(=O)=O)=C(Cl)C=C2N([Si](C)(C)C)C1C | 3270.2 | Standard non polar | 33892256 | Metolazone,1TMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(N)(=O)=O)=C(Cl)C=C2N([Si](C)(C)C)C1C | 4426.1 | Standard polar | 33892256 | Metolazone,2TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C2NC1C | 3046.3 | Semi standard non polar | 33892256 | Metolazone,2TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C2NC1C | 3346.0 | Standard non polar | 33892256 | Metolazone,2TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C2NC1C | 4123.1 | Standard polar | 33892256 | Metolazone,2TMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C)=C(Cl)C=C2N([Si](C)(C)C)C1C | 2963.9 | Semi standard non polar | 33892256 | Metolazone,2TMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C)=C(Cl)C=C2N([Si](C)(C)C)C1C | 3329.3 | Standard non polar | 33892256 | Metolazone,2TMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C)=C(Cl)C=C2N([Si](C)(C)C)C1C | 3823.9 | Standard polar | 33892256 | Metolazone,3TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C2N([Si](C)(C)C)C1C | 2995.4 | Semi standard non polar | 33892256 | Metolazone,3TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C2N([Si](C)(C)C)C1C | 3494.3 | Standard non polar | 33892256 | Metolazone,3TMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C2N([Si](C)(C)C)C1C | 3776.4 | Standard polar | 33892256 | Metolazone,1TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=C2NC1C | 3343.3 | Semi standard non polar | 33892256 | Metolazone,1TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=C2NC1C | 3440.9 | Standard non polar | 33892256 | Metolazone,1TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=C2NC1C | 4217.3 | Standard polar | 33892256 | Metolazone,1TBDMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(N)(=O)=O)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3248.6 | Semi standard non polar | 33892256 | Metolazone,1TBDMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(N)(=O)=O)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3475.5 | Standard non polar | 33892256 | Metolazone,1TBDMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(N)(=O)=O)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 4481.6 | Standard polar | 33892256 | Metolazone,2TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C2NC1C | 3524.7 | Semi standard non polar | 33892256 | Metolazone,2TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C2NC1C | 3828.2 | Standard non polar | 33892256 | Metolazone,2TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C2NC1C | 4120.2 | Standard polar | 33892256 | Metolazone,2TBDMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3410.1 | Semi standard non polar | 33892256 | Metolazone,2TBDMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3814.2 | Standard non polar | 33892256 | Metolazone,2TBDMS,isomer #2 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3915.4 | Standard polar | 33892256 | Metolazone,3TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3656.1 | Semi standard non polar | 33892256 | Metolazone,3TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 4204.7 | Standard non polar | 33892256 | Metolazone,3TBDMS,isomer #1 | CC1=CC=CC=C1N1C(=O)C2=CC(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C2N([Si](C)(C)C(C)(C)C)C1C | 3906.7 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Metolazone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f8j-3597000000-ad3d0d3d7130fb037587 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Metolazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Metolazone LC-ESI-qTof , Positive-QTOF | splash10-0aor-1494000000-aae5f0a5c86e9d0828e2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metolazone LC-ESI-qTof , Positive-QTOF | splash10-0bvi-2960000000-1eed022b28a6bb140f60 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metolazone , positive-QTOF | splash10-0aor-1494000000-aae5f0a5c86e9d0828e2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Metolazone , positive-QTOF | splash10-0bvi-2960000000-1eed022b28a6bb140f60 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 10V, Positive-QTOF | splash10-014i-0009000000-a2ec696223204fee136f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 20V, Positive-QTOF | splash10-014i-0279000000-4b5932a93a7777aa9293 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 40V, Positive-QTOF | splash10-0zfr-2492000000-e56f6f011b99c12fe90e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 10V, Negative-QTOF | splash10-03di-0009000000-c969b7886e22277846ed | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 20V, Negative-QTOF | splash10-01t9-8119000000-fb2264110d55cdd31ad4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 40V, Negative-QTOF | splash10-004i-9110000000-7cb0633c91fcbb9b8881 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 10V, Negative-QTOF | splash10-03di-0009000000-1e4f596ff037e4c41189 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 20V, Negative-QTOF | splash10-03di-2009000000-2d6cdb71493d37e99073 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 40V, Negative-QTOF | splash10-003r-9321000000-3e5878b7c7d017a45529 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 10V, Positive-QTOF | splash10-014i-0009000000-6789fa47262c2e6bd71a | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 20V, Positive-QTOF | splash10-014i-0009000000-eb6980c64348c1d78ad9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Metolazone 40V, Positive-QTOF | splash10-0kai-4892000000-6b2c2e53c19f2fd5f60d | 2021-09-24 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00524 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00524 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00524 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4026 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Metolazone |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 4170 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 64354 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Rosenberg J, Gustafsson F, Galatius S, Hildebrandt PR: Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Cardiovasc Drugs Ther. 2005 Aug;19(4):301-6. [PubMed:16189620 ]
|
---|